Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mateja, Krajc"'
Autor:
Ksenija Strojnik, Vita Setrajcic Dragos, Srdjan Novaković, Vida Stegel, Ana Blatnik, Mateja Krajc
Publikováno v:
Breast Cancer Research and Treatment
Purpose To analyze the prevalence of pathogenic/likely pathogenic variants (P/LPVs) in BRCA1 and BRCA2 genes in the largest cohort of Slovenian male breast cancer (MBC) patients to date and to explore a possible correlation between the Slovenian foun
Autor:
Barbara Gazic, Tea Nizic-Kos, Vida Stegel, Nikola Besic, Srdjan Novaković, Ana Blatnik, Petra Škerl, Mateja Krajc
Publikováno v:
Annals of Surgical Oncology. 28:2561-2570
Currently, data on pathogenic variants in the CHEK2 gene and their impact on cancer risk are lacking. This study aimed to explore the characteristics of breast cancer (BC) patients from families with CHEK2 pathogenic variants in Slovenia. In the year
Autor:
Vida Stegel, Barbara Gazic, Mateja Krajc, Ana Blatnik, Andraz Perhavec, Srdjan Novaković, Sebastijan Merlo, Andreja Gornjec
Publikováno v:
Radiology and Oncology, Vol 54, Iss 2, Pp 180-186 (2020)
Radiology and Oncology
Radiology and Oncology
Background We assessed the prevalence, localization, type and outcome of occult cancer at risk-reducing salpingo-oophorectomy or salpingectomy (RRSO) in asymptomatic carriers of pathogenic or likely pathogenic BRCA1/2 variants and high-risk BRCA1/2 n
Autor:
David Humberto Marmolejo, Mark Yu Zheng Wong, Svetlana Bajalica-Lagercrantz, Marc Tischkowitz, Judith Balmaña, Attila Balázs Patócs, Pierre Chappuis, Chrystelle Colas, Maurizio Genuardi, Maria Haanpää, Hildegunn Hoberg Vetti, Nicoline Hoogerbrugge, Arvids Irmejs, Tiina Kahre, Barbara Klink, Mateja Krajc, Tamara Hussong Milagre, Robin de Putter, Verena Steinke-Lange, Karin Wadt, Katharina Wimmer
Publikováno v:
European Journal of Medical Genetics, 64, 12
European Journal of Medical Genetics, 64
European Journal of Medical Genetics, 64
Item does not contain fulltext Hereditary breast and ovarian cancer (HBOC) is a syndrome defined by an increased risk of developing breast and/or ovarian cancer most commonly due to germline disease-causing variants in the BRCA1 and BRCA2 genes, but
Autor:
Giovanna Masala, Susan L. Neuhausen, Montserrat Garcia Closas, Vasilios Georgoulias, Paul D.P. Pharoah, Katarzyna Tomczyk, Henrik Flyger, Håkan Olsson, D. Timothy Bishop, Alison M. Dunning, Eitan Friedman, Matthew Pugh, Michael Jones, Johanna Mattson, Sarah Maguire, Richard S. Houlston, Paul A. James, Douglas F. Easton, Valentina Silvestri, Srdjan Novaković, Rosie Cooke, Maartje J. Hooning, Eleni Perraki, Manuela Gago-Dominguez, Domenico Palli, Laura Ottini, Nick Orr, Kyle Thompson, Heli Nevanlinna, Yael Laitman, Antoinette Hollestelle, Stig E. Bojesen, Timothy Winter, Alison H. Trainer, Ines Zanna, Mateja Krajc, Linda Steele, Jose E. Castelao, Emmanouil Saloustros, Olivia Fletcher, Ingrid Hedenfalk, Alan Ashworth, Anthony J. Swerdlow
Publikováno v:
Maguire, S, Perrakis, E, Tomczyk, K, Jones, M, Fletcher, O, Pugh, M, Winter, T, Thompson, K, Cooke, R, Trainer, A H, Paul, J, Bojesen, S E, Flyger, H, Nevanlinna, H, Mattson, J, Friedman, E, Laitman, Y, Palli, D, Masala, G, Zanna, I, Ottini, L, Silvestri, V, Hollestelle, A, Hooning, M J, Novaković, S, Krajc, M, Gago-Dominguez, M, Castelao, J E, Olsson, H, Hedenfalk, I, Saloustros, E, Georgoulias, V, Easton, D F, Pharoah, P, Dunning, A M, Timothy Bishop, D, Neuhausen, S L, Steele, L, Ashworth, A, García-Closas, M, Houlston, R, Swerdlow, A J & Orr, N 2020, ' Common susceptibility loci for male breast cancer ', Journal of the National Cancer Institute, vol. 2020, dja101 . https://doi.org/10.1093/jnci/djaa101
Journal of the National Cancer Institute, 113(4), 453-461. Oxford University Press
JNCI Journal of the National Cancer Institute
Maguire, S, Perraki, E, Tomczyk, K, Jones, M E, Fletcher, O, Pugh, M, Winter, T, Thompson, K, Cooke, R, Trainer, A, James, P, Bojesen, S, Flyger, H, Nevanlinna, H, Mattson, J, Friedman, E, Laitman, Y, Palli, D, Masala, G, Zanna, I, Ottini, L, Silvestri, V, Hollestelle, A, Hooning, M J, Novaković, S, Krajc, M, Gago-dominguez, M, Castelao, J E, Olsson, H, Hedenfalk, I, Saloustros, E, Georgoulias, V, Easton, D F, Pharoah, P, Dunning, A M, Bishop, D T, Neuhausen, S L, Steele, L, Ashworth, A, Garcia Closas, M, Houlston, R, Swerdlow, A & Orr, N 2021, ' Common Susceptibility Loci for Male Breast Cancer ', National Cancer Institute. Journal (Online), vol. 113, no. 4, pp. 453-461 . https://doi.org/10.1093/jnci/djaa101
Journal of the National Cancer Institute, 113(4), 453-461. Oxford University Press
JNCI Journal of the National Cancer Institute
Maguire, S, Perraki, E, Tomczyk, K, Jones, M E, Fletcher, O, Pugh, M, Winter, T, Thompson, K, Cooke, R, Trainer, A, James, P, Bojesen, S, Flyger, H, Nevanlinna, H, Mattson, J, Friedman, E, Laitman, Y, Palli, D, Masala, G, Zanna, I, Ottini, L, Silvestri, V, Hollestelle, A, Hooning, M J, Novaković, S, Krajc, M, Gago-dominguez, M, Castelao, J E, Olsson, H, Hedenfalk, I, Saloustros, E, Georgoulias, V, Easton, D F, Pharoah, P, Dunning, A M, Bishop, D T, Neuhausen, S L, Steele, L, Ashworth, A, Garcia Closas, M, Houlston, R, Swerdlow, A & Orr, N 2021, ' Common Susceptibility Loci for Male Breast Cancer ', National Cancer Institute. Journal (Online), vol. 113, no. 4, pp. 453-461 . https://doi.org/10.1093/jnci/djaa101
BackgroundThe aetiology of male breast cancer (MBC) is poorly understood. In particular, the extent to which the genetic basis of MBC differs from female breast cancer (FBC) is unknown. A previous genome-wide association study (GWAS) of MBC identifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99cf7e99c539a55981e4d31bff3d1fde
https://pure.qub.ac.uk/en/publications/549ad521-1148-4008-b767-1a9f0ecf4a66
https://pure.qub.ac.uk/en/publications/549ad521-1148-4008-b767-1a9f0ecf4a66
Publikováno v:
Radiology and Oncology
Radiology and Oncology, Vol 54, Iss 3, Pp 335-340 (2020)
Radiology and oncology, str. 335-340, X, Vol. 54, no. 3, 2020 : Tabele
COBISS-ID: 32649472
Radiology and Oncology, Vol 54, Iss 3, Pp 335-340 (2020)
Radiology and oncology, str. 335-340, X, Vol. 54, no. 3, 2020 : Tabele
COBISS-ID: 32649472
Background The aim of the study was to assess the proportion of women that would be classified as at above-average risk of breast cancer based on the 10 year-risk prediction of the Slovenian breast cancer incidence rate (S-IBIS) program in two presum
Autor:
Andreja Gornjec, Erik Škof, Marko Hočevar, Vida Stegel, Barbara Gazic, Ziva Pohar Marinsek, Srdjan Novaković, Mateja Krajc
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Background High-grade serous ovarian cancer is a detrimental disease. Treatment options in patients with a recurrent disease are dependent on BRCA1/2 mutation status since only patients with known BRCA mutation are eligible for treatment with poly(AD
Autor:
Janez Zgajnar, Mateja Krajc, Katarina Lokar, Srdan Novakovic, Barabara Cernivc, Jacques De Greve, Erik Teugels, Nikola Besic
Publikováno v:
Vrije Universiteit Brussel
Male breast cancer (MBC) is a rare disease, comprising less than 1% of breast cancer patients in Slovenia. Some inherited cases are due to the mutations of BRCA1 or BRCA2 genes. There is no information available about the frequency of BRCA gene mutat
Autor:
Marko Hočevar, Petra Cerkovnik, Mateja Krajc, Srdjan Novaković, Janez Žgajnar, Vida Stegel, Aleš Vakselj, Maša Milatovič
Publikováno v:
International Journal of Oncology
The estimated proportion of hereditary breast and ovarian cancers among all breast and ovarian cancer cases is 5-10%. According to the literature, inherited mutations in the BRCA1 and BRCA2 tumour-suppressor genes, account for the majority of heredit
Autor:
Erik Teugels, Marko Hočevar, Vida Stegel, Srdjan Novaković, Jacques De Greve, Mateja Krajc, Janez Žgajnar
Publikováno v:
BMC Medical Genetics
Vrije Universiteit Brussel
BMC Medical Genetics, Vol 12, Iss 1, p 9 (2011)
Vrije Universiteit Brussel
BMC Medical Genetics, Vol 12, Iss 1, p 9 (2011)
Background The BRCA1 and BRCA2 mutation spectrum and mutation detection rates according to different family histories were investigated in 521 subjects from 322 unrelated Slovenian cancer families with breast and/or ovarian cancer. Methods The BRCA1